Raffles Hospital Extension


Keong Hong reports 86% rise in full-year earnings to $70.2 mil on fair value gains

SINGAPORE (Nov 28): Keong Hong Holdings, the homegrown property construction, development and investment group, reported earnings of $70.2 million for the FY17 ended Sept.

Broker's Calls

Buy, hold or sell Raffles Medical Group? These brokerages have no common ground

SINGAPORE (Feb 21): The research houses of CIMB, RHB and DBS are reiterating their divided opinions on Raffles Medical Group after it on Monday reported a 1.3% rise in FY16 earnings  to $70.2 million on higher revenue.

Raffles Medical’s FY16 earnings rise 1.3% to $70.2 mil on higher revenue

SINGAPORE (Feb 20): Raffles Medical Group reported earnings of $70.2 million for the full year ended Dec 31, 1.3% higher than the $69.3 million it posted in FY15.

Broker's Calls

More patients. Expansion on track. So, what could go wrong for Raffles Medical?

SINGAPORE (Jan 19): Much has been said about Raffles Medical Group’s growth potential this year.


Raffles Medical’s 3Q earnings up 4% to $16.2 mil on higher revenue

SINGAPORE (Oct 9): Raffles Medical Group announced a 4% rise in 3Q earnings to $16.2 million from $15.6 million the year before, due to positive revenue contributions from all segments of the group.

Broker's Calls

Raffles Medical has more room for growth

SINGAPORE (Oct 17): After posting 5% earnings growth in 2QFY16, RHB Research Cai is still maintaining its “buy” rating on the stock with a target price of $1.70 as it believes the group has more room to grow.